Core Viewpoint - Rosen Law Firm is reminding investors who purchased Marex Group plc securities during the specified Class Period of the upcoming lead plaintiff deadline on December 8, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - The class action pertains to securities purchased between May 16, 2024, and August 5, 2025, with a lead plaintiff deadline set for December 8, 2025 [1][2]. - Investors may join the class action through the provided link or contact information, and serving as a lead plaintiff requires a court motion by the deadline [2][5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements among subsidiaries [4]. - As a result of these actions, Marex's financial statements were deemed unreliable, leading to misleading positive statements about the company's business and operations [4].

Core Viewpoint - Rosen Law Firm is urging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action related to misleading statements made during the Class Period from May 16, 2024, to August 5, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, which involves directing the litigation on behalf of other class members [3][7]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4].

Core Viewpoint - The Rosen Law Firm is encouraging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to misleading financial statements and practices during the Class Period from May 16, 2024, to August 5, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 8, 2025 deadline to serve as lead plaintiff, representing other class members in the litigation [3]. - The lawsuit alleges that Marex made materially false and misleading statements regarding its financial practices, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in achieving significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4].

Core Viewpoint - Marex Group plc is facing a potential class action lawsuit due to allegations of securities law violations, including misleading financial statements and undisclosed financial practices [5][6][2]. Group 1: Legal Action and Investigation - Faruqi & Faruqi, LLP is investigating claims against Marex Group and has set a deadline of December 8, 2025, for investors to seek the role of lead plaintiff in the class action lawsuit [2]. - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact the law firm to discuss their legal rights [1][2]. Group 2: Allegations Against Marex - The complaint alleges that Marex and its executives made false or misleading statements and failed to disclose critical financial information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - A report by NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [6]. Group 3: Market Reaction - Following the release of the NINGI Research report, Marex's stock price dropped by 6.2%, closing at $35.31 with significant trading volume [8].

Core Points - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the Class Period from May 16, 2024, to August 5, 2025, to secure legal counsel before the December 8, 2025, deadline for lead plaintiff applications [1][2]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements, which led to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 16, 2024, and August 5, 2025, which has adversely affected investors [1][2] Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2] - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record, having secured hundreds of millions of dollars for shareholders over the past 20 years and is recognized as one of the top securities litigation firms in the United States [4]

Group 1 - The Value Lab focuses on long-only value investment ideas, aiming for a portfolio yield of approximately 4% and has performed well over the last five years by engaging in international markets [1][2] - The Valkyrie Trading Society consists of analysts who share high conviction and obscure developed market ideas, targeting downside-limited investments that are expected to yield non-correlated and outsized returns in the current economic environment [2] - The Value Lab provides members with real-time portfolio updates, 24/7 chat support, regular global market news reports, feedback on stock ideas, monthly new trades, quarterly earnings write-ups, and daily macro opinions [2]

Core Viewpoint - Class action lawsuits have been filed against several publicly-traded companies, alleging that these companies made materially false and misleading statements regarding their business operations and financial prospects, which have adversely affected shareholders [1]. Company Summaries Molina Healthcare, Inc. (NYSE: MOH) - Class Period: February 5, 2025 – July 23, 2025 - Allegations include failure to disclose adverse facts about medical cost trend assumptions and a dislocation between premium rates and medical costs, leading to a likely cut in financial guidance for fiscal year 2025 [2]. Marex Group plc (NASDAQ: MRX) - Class Period: May 16, 2024 – August 5, 2025 - Allegations include selling over-the-counter financial instruments to itself and inconsistencies in financial statements, making the financial data unreliable [3]. aTyr Pharma Inc. (NASDAQ: ATYR) - Class Period: November 7, 2024 – September 12, 2025 - Allegations include misleading statements regarding the study design for EFZO-FIT and the failure to meet primary endpoints, which misrepresented the company's prospects [4]. WPP plc (NYSE: WPP) - Class Period: February 27, 2025 – July 8, 2025 - Allegations include the media arm's inability to handle macroeconomic challenges and loss of market share, rendering positive statements about the company's operations misleading [6].

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that inflated its financial metrics, impacting investors negatively between May 16, 2024, and August 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2]. - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record, having secured hundreds of millions of dollars for shareholders over the past 20 years and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - The Rosen Law Firm is encouraging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit related to misleading financial statements and practices during the Class Period from May 16, 2024, to August 5, 2025 [2][6]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements between subsidiaries [6]. - The lawsuit claims that these misleading statements resulted in investor damages when the true details became public [6]. Group 2: Next Steps for Investors - To join the class action, investors can visit the provided link or contact the law firm directly for more information [4][7]. - A lead plaintiff must be appointed by December 8, 2025, to represent other class members in the litigation [4]. - Investors have the option to select their counsel or remain absent from the class at this stage [8]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [5]. - The firm was ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions for investors over the years [5].